How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer

calendar_today February 24, 2026 person fernando domain cartography-biosciences